Su-Yau Mao

Title: Su-Yau Mao: Innovator in High Affinity Antibodies

Introduction

Su-Yau Mao is a prominent inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of high affinity antibodies. With a total of 4 patents, her work focuses on therapeutic applications for inflammatory diseases.

Latest Patents

One of her latest patents involves high affinity antibodies against HMGB1 and methods of use thereof. This invention discloses compositions and methods for inhibiting the release of proinflammatory cytokines from vertebrate cells. The high affinity antibodies specifically bind to HMGB1 and its antigenic fragments. These antibodies are designed to serve as therapeutics for a wide range of inflammatory diseases and disorders, including sepsis, rheumatoid arthritis, and Crohn's disease. Additionally, they are useful as diagnostic antibodies, providing a dual purpose in both treatment and diagnosis.

Career Highlights

Throughout her career, Su-Yau Mao has worked with notable organizations such as MedImmune Limited and the Feinstein Institute for Medical Research. Her innovative research has positioned her as a key figure in the biotechnology sector, contributing to advancements in medical treatments.

Collaborations

Su-Yau has collaborated with esteemed colleagues, including Herren Wu and Changshou Gao. These partnerships have further enhanced her research and development efforts in the field of high affinity antibodies.

Conclusion

Su-Yau Mao's contributions to the field of biotechnology through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to impact the treatment of inflammatory diseases, showcasing the importance of research and innovation in healthcare.